Gregory Bailey
Director · Serina Therapeutics, Inc.
- 2024
- Jun 22, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory Bailey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John W. Childs - $25.86M in BHVN purchases and sales in the last 12 months
- Vlad Coric - $5.00M in BHVN purchases and sales in the last 12 months
- Randall Moreadith - $377K in SER purchases and sales in the last 12 months
- George C. Clark - $145K in BHVN purchases and sales in the last 12 months
- Karen J. Wilson - $55K in SER purchases and sales in the last 12 months
- Richard Peter Marshall - $20K in SER purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory Bailey?
Gregory Bailey is a corporate insider, tracked as Director of Serina Therapeutics, Inc. (SER). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gregory Bailey last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 6 filings going back to 2024.
Has Gregory Bailey been buying or selling stock?
Recorded transactions: 2 open-market purchases ($3.02M) and 0 open-market sales across all tracked filings.
